Randomized, placebo-controlled, phase II trial of EGFR and COX-2 inhibition in advanced non-small cell lung cancer

被引：0
|
作者：
Reckamp, K. L.
Koczywas, M.
Cristea, M. C.
Dowell, J.
Gardner, B.
Milne, G.
Rad, S. Fouladi
Figlin, R. A.
Elashoff, R.
Dubinett, S. M.
机构：
[1] City Hope Natl Med Ctr, Duarte, CA USA
[2] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[4] Vanderbilt Univ, Nashville, TN 37235 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.tps337
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS337
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Plasma biomarkers in a phase II trial of sorafenib in advanced non-small cell lung cancer
    Pena, Carol
    Gatzemeier, Ulrich
    Lathia, Chetan
    Fossella, Frank
    Reck, Martin
    Elting, James
    Blumenschein, George R.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3438S - 3439S
  • [42] PHASE-II TRIAL OF ANAXIRONE IN ADVANCED NON-SMALL CELL LUNG-CANCER
    FIEBIG, HH
    HENSS, H
    ARNOLD, H
    VONBULTZINGSLOWEN, F
    KLEE, M
    QUEISSER, W
    PEUKERT, M
    CANCER TREATMENT REPORTS, 1987, 71 (05): : 539 - 540
  • [43] Phase II trial of docetaxel and carboplatin in the treatment of advanced non-small cell lung cancer
    Schutte, W
    Bork, I
    Wollschlager, B
    Schadlich, S
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1076 - 1076
  • [44] A phase II trial of CI-980 in advanced non-small cell lung cancer
    Vokes, EE
    Arrieta, R
    Lad, T
    Masters, GA
    Hoffman, PC
    Ansari, R
    Schumm, P
    Golomb, HM
    ANNALS OF ONCOLOGY, 1998, 9 : 100 - 100
  • [45] Chemotherapy of advanced inoperable non-small cell lung cancer with paclitaxel: A phase II trial
    Gatzemeier, U
    Heckmayer, M
    Neuhauss, R
    Schluter, I
    vonPawel, J
    Wagner, H
    Dreps, A
    SEMINARS IN ONCOLOGY, 1995, 22 (06) : 24 - 28
  • [46] PHASE-II TRIAL OF AMINOTHIADIAZOLE IN ADVANCED NON-SMALL CELL LUNG-CANCER
    SHEVRIN, DH
    MCGUIRE, WP
    LANZOTTI, V
    KRAUSS, S
    BLOUGH, R
    COBLEIGH, M
    JOHNSON, C
    LAD, T
    KUKLA, L
    CANCER TREATMENT REPORTS, 1986, 70 (03): : 417 - 418
  • [47] Ifosfamide and gemcitabine: A phase II trial in advanced inoperable non-small cell lung cancer
    Gatzemeier, U
    Manegold, C
    Eberhard, W
    Wilke, HJ
    Chomy, F
    Chomy, P
    Khayat, D
    Blatter, J
    Seeber, S
    Drings, P
    SEMINARS IN ONCOLOGY, 1998, 25 (01) : 15 - 18
  • [48] Continuing EGFR inhibition beyond progression in advanced non-small cell lung cancer
    Yap, Timothy A.
    Macklin-Doherty, Aislinn
    Popat, Sanjay
    EUROPEAN JOURNAL OF CANCER, 2017, 70 : 12 - 21
  • [49] A Randomized, Multicenter, Placebo-Controlled Clinical Trial of Racotumomab-Alum Vaccine as Switch Maintenance Therapy in Advanced Non-Small Cell Lung Cancer Patients
    Alfonso, Sailyn
    Valdes-Zayas, Anet
    Santiesteban, Eduardo R.
    Flores, Yoanna I.
    Areces, Fernando
    Hernandez, Maurenis
    Viada, Carmen E.
    Mendoza, Ivis C.
    Guerra, Pedro P.
    Garcia, Elena
    Ortiz, Ramon A.
    de la Torre, Ana V.
    Cepeda, Meylan
    Perez, Kirenia
    Chong, Eric
    Maria Hernandez, Ana
    Toledo, Darien
    Gonzalez, Zuyen
    Mazorra, Zaima
    Crombet, Tania
    Perez, Rolando
    Maria Vazquez, Ana
    Macias, Amparo E.
    CLINICAL CANCER RESEARCH, 2014, 20 (14) : 3660 - 3671
  • [50] Vitamin D Supplementation and Survival of Patients with Non-small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial
    Akiba, Tadashi
    Morikawa, Toshiaki
    Odaka, Makoto
    Nakada, Takeo
    Kamiya, Noriki
    Yamashita, Makoto
    Yabe, Mitsuo
    Inagaki, Takuya
    Asano, Hisatoshi
    Mori, Shohei
    Tsukamoto, Yo
    Urashima, Mitsuyoshi
    CLINICAL CANCER RESEARCH, 2018, 24 (17) : 4089 - 4097
12345